跳至主要内容
临床试验/NCT02711839
NCT02711839已完成不适用

Office of Human Research, Taipei Medical University

Taipei Medical University0 个研究点目标入组 54 人开始时间: 2015年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
54
主要终点
HbA1c After Intervention

研究概览

简要总结

In order to response the increasing of aging population cause losing ability that need long-care needs, the project entitled "10-year long-term care program" from Executive Yuan in 2007 is carried out to assist economically disadvantaged and disabled elderly to acquire daily nutrition. Therefore, the long-term care resident's nutritional status got more attention than before. Out of control in blood glucose will not only increase bed sores and urinary tract infection in tube feeding residents but also rise medical expenditures. The nutritional status of long-term care institutions, anyang homes and nursing home are generally bad in nutrition management due to high cost of nutritional supplements from foreign imports that cause the burden of families. In this study, we will recruit diabetic subjects that divide into white sweet potato group (experimental group) and commercial formula group (control group) by using randomized, parallel and open clinical study through tube feeding in sixty days.

详细描述

All subjects will be evaluated the blood sugar and clinical nutrition assessment such as postural measurement, urine test and blood biomarker examination.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Long-term stability nasogastric or gastrostomy-fed person.
  • The physician diagnosed as diabetic and regular use of hypoglycemic drugs.

排除标准

  • Psychosis or depression.
  • Hba1c> 8.5%.
  • High taking nutritional supplements or steroids drugs.
  • Have undergone abdominal surgery caused by intestinal sticky.
  • Suffering from cancer, ulcers, respiratory infections and other diseases.
  • Currently receiving central venous nutrition therapy or intravenous nutrition therapy.
  • Liver dysfunction (ALT ≧ 100 U / L), renal insufficiency (creatinine ≧ 3mg / dl), heart failure (NYFc II above), moderate anemia (hemoglobin <9 g / dl).

研究组 & 干预措施

Control Group

Placebo Comparator

Commercial diabetic formula

干预措施: Commercial diabetic formula (Dietary Supplement)

Treatment Group

Experimental

White sweet potato formula

干预措施: White sweet potato formula (Dietary Supplement)

结局指标

主要结局

HbA1c After Intervention

时间窗: 60 days

HbA1c value after 60 days intervention in both groups

次要结局

  • Albumin After Intervention(60 days)
  • Glucose After Intervention(60 days)
  • Total Cholesterol After Intervention(60 days)
  • Triglyceride After Intervention(60 days)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Evaluation of White Sweet Potato Tube Feeding... | 临床试验